ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,331, issued on Oct. 27, was assigned to KYOWA KIRIN Co. LTD. (Tokyo). "Bispecific antibody binding to CD3" was invented by Rinpei Niwa (Tok... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,332, issued on Oct. 27, was assigned to Genentech Inc. (South San Francisco, Calif.). "Anti-CD8 antibodies and uses thereof" was invented b... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,333, issued on Oct. 27, was assigned to The Regents of the University of California (Oakland, Calif.). "Compositions and methods for making... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,334, issued on Oct. 27, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany). "B7H6 x CD3 binding proteins... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,335, issued on Oct. 27, was assigned to Nexoplex Bio LLC (Jackson, Wyo.). "Antigen-binding proteins and related methods of use" was invente... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,336, issued on Oct. 27, was assigned to The Johns Hopkins University (Baltimore). "MANAbodies and methods of using" was invented by Emily H... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,337, issued on Oct. 27, was assigned to DIZAL PHARMACEUTICAL Co. LTD. (Wuxi, China). "Anti-FGFR2b antibodies" was invented by Mei Wang (Sha... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,338, issued on Oct. 27, was assigned to Astellas Pharma Inc. (Tokyo). "Multispecific antibody binding to ActRIIA, ActRIIB, and Fn14" was in... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,339, issued on Oct. 27, was assigned to ETABLISSEMENT FRANCAIS DU SANG (La Plaine Saint-Denis Cedex, France), INSTITUT NATIONAL DE LA SANTA ... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,340, issued on Oct. 27, was assigned to BIOTHEUS INC. (Zhuhai, China). "Anti-4-1BB single-domain antibodies, nanobodies, fusion proteins th... Read More